Evidence map›Paper›PMID 36170988›Full record

Trial reportBMJ (Clinical research ed.)2022

Effectiveness of a behavioural intervention delivered by text messages (safetxt) on sexually transmitted reinfections in people aged 16-24 years: randomised controlled trial.

Caroline Free, Melissa J Palmer, Ona L McCarthy, Lauren Jerome, Sima Berendes, Megan Knight, James R Carpenter, Tim P Morris, Zahra Jamal, Farandeep Dhaliwal and 15 more

Erratum issuedOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 1 country.

Caroline FreeClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-1711-0006
Melissa J PalmerClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Ona L McCarthyClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Lauren JeromeClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Sima BerendesClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Megan KnightClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
James R CarpenterClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Tim P MorrisMRC Clinical Trials Unit, London, UK.
Zahra JamalClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Farandeep DhaliwalClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Rebecca S FrenchDepartment of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK.
Ford Colin Ian HicksonSigma Research, London School of Hygiene and Tropical Medicine, London, UK.
Anasztazia GubijevClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Kaye WellingsDepartment of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, UK.
Paula BaraitserCentre for Global Health, King's College London, London, UK.
Ian RobertsClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Julia V BaileyeHealth Unit, Research Department of Primary care and Population Health, University College London, London, UK.
Tim ClaytonClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Karen DevriesDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Phil EdwardsClinical Trials Unit, Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Graham HartDepartment of Infection and Population Health, University College London, London, UK.
Susan MichieCentre for Outcomes Research and Effectiveness, University College London, London, UK.
Louis MacgregorBristol Veterinary School, University of Bristol, Bristol, UK.
Katy M E TurnerBristol Veterinary School, University of Bristol, Bristol, UK.
Kimberley PotterClinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBUniversity College London · GBRoyal Society of Tropical Medicine and Hygiene · GBUniversity of Bristol · GBKing's College London · GBMRC Clinical Trials Unit at UCL · GB

Funding

Medical Research Council MC_UU_00004/03Medical Research Council MC_UU_00004/07
6 · The paper itself

Abstract

objectiveTo quantify the effects of a series of text messages (safetxt) delivered in the community on incidence of chlamydia and gonorrhoea reinfection at one year in people aged 16-24 years.

designParallel group randomised controlled trial.

setting92 sexual health clinics in the United Kingdom.

participantsPeople aged 16-24 years with a diagnosis of, or treatment for, chlamydia, gonorrhoea, or non-specific urethritis in the past two weeks who owned a mobile phone.

interventions3123 participants assigned to the safetxt intervention received a series of text messages to improve sex behaviours: four texts daily for days 1-3, one or two daily for days 4-28, two or three weekly for month 2, and 2-5 monthly for months 3-12. 3125 control participants received a monthly text message for one year asking for any change to postal or email address. It was hypothesised that safetxt would reduce the risk of chlamydia and gonorrhoea reinfection at one year by improving three key safer sex behaviours: partner notification at one month, condom use, and sexually transmitted infection testing before unprotected sex with a new partner. Care providers and outcome assessors were blind to allocation.

main outcome measuresThe primary outcome was the cumulative incidence of chlamydia or gonorrhoea reinfection at one year, assessed by nucleic acid amplification tests. Safety outcomes were self-reported road traffic incidents and partner violence. All analyses were by intention to treat.

results6248 of 20 476 people assessed for eligibility between 1 April 2016 and 23 November 2018 were randomised. Primary outcome data were available for 4675/6248 (74.8%). At one year, the cumulative incidence of chlamydia or gonorrhoea reinfection was 22.2% (693/3123) in the safetxt arm versus 20.3% (633/3125) in the control arm (odds ratio 1.13, 95% confidence interval 0.98 to 1.31). The number needed to harm was 64 (95% confidence interval number needed to benefit 334 to ∞ to number needed to harm 24) The risk of road traffic incidents and partner violence was similar between the groups.

conclusionsThe safetxt intervention did not reduce chlamydia and gonorrhoea reinfections at one year in people aged 16-24 years. More reinfections occurred in the safetxt group. The results highlight the need for rigorous evaluation of health communication interventions.

trial registrationISRCTN registry ISRCTN64390461.

Indexed as

GonorrheaSexually Transmitted DiseasesText MessagingHumansReinfectionSexual Behavior

Identifiers

PMID36170988
PMCPMC9516322
OpenAlexW4297470975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.